BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1207807 Cc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H30ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- RJDONMRZHDZWMR-WAYWQWQTSA-N 572148 (rac)-(11Z)-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,13,15-tetrahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 1::US11478451, Example 1 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 6.10 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572148&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591086 473133220 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207808 Cc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H30ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- RJDONMRZHDZWMR-WAYWQWQTSA-N 572148 (rac)-(11Z)-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,13,15-tetrahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 1::US11478451, Example 1 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572148&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591086 473133220 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207809 Cc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H30ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- RJDONMRZHDZWMR-WAYWQWQTSA-N 572148 (rac)-(11Z)-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,13,15-tetrahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 1::US11478451, Example 1 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572148&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591086 473133220 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207810 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.60 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207811 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207812 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207813 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207814 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 38.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207815 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207816 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.600 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207817 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207818 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207819 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 33.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207820 Cc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C37H41ClN4O5/c1-25-33-31(42(39-25)17-16-40-18-22-45-23-19-40)24-46-20-5-4-15-41-35-29(13-14-30(38)34(33)35)28(36(41)37(43)44)11-7-21-47-32-12-6-9-26-8-2-3-10-27(26)32/h2-3,6,8-10,12-14H,4-5,7,11,15-24H2,1H3,(H,43,44) CFEBGYDMHHPZMA-UHFFFAOYSA-N 572155 (rac)-4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 8::US11447504, Example 9 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.890 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572155&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 157561098 473133223 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207821 Cc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C37H41ClN4O5/c1-25-33-31(42(39-25)17-16-40-18-22-45-23-19-40)24-46-20-5-4-15-41-35-29(13-14-30(38)34(33)35)28(36(41)37(43)44)11-7-21-47-32-12-6-9-26-8-2-3-10-27(26)32/h2-3,6,8-10,12-14H,4-5,7,11,15-24H2,1H3,(H,43,44) CFEBGYDMHHPZMA-UHFFFAOYSA-N 572155 (rac)-4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 8::US11447504, Example 9 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.470 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572155&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 157561098 473133223 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207822 Cc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C37H41ClN4O5/c1-25-33-31(42(39-25)17-16-40-18-22-45-23-19-40)24-46-20-5-4-15-41-35-29(13-14-30(38)34(33)35)28(36(41)37(43)44)11-7-21-47-32-12-6-9-26-8-2-3-10-27(26)32/h2-3,6,8-10,12-14H,4-5,7,11,15-24H2,1H3,(H,43,44) CFEBGYDMHHPZMA-UHFFFAOYSA-N 572155 (rac)-4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 8::US11447504, Example 9 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572155&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 157561098 473133223 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207823 Cc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C37H41ClN4O5/c1-25-33-31(42(39-25)17-16-40-18-22-45-23-19-40)24-46-20-5-4-15-41-35-29(13-14-30(38)34(33)35)28(36(41)37(43)44)11-7-21-47-32-12-6-9-26-8-2-3-10-27(26)32/h2-3,6,8-10,12-14H,4-5,7,11,15-24H2,1H3,(H,43,44) CFEBGYDMHHPZMA-UHFFFAOYSA-N 572155 (rac)-4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 8::US11447504, Example 9 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572155&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 157561098 473133223 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207824 CCc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C38H43ClN4O5/c1-2-31-35-32(43(40-31)18-17-41-19-23-46-24-20-41)25-47-21-6-5-16-42-36-29(14-15-30(39)34(35)36)28(37(42)38(44)45)12-8-22-48-33-13-7-10-26-9-3-4-11-27(26)33/h3-4,7,9-11,13-15H,2,5-6,8,12,16-25H2,1H3,(H,44,45) WDKPDJPIUJQOAB-UHFFFAOYSA-N 572157 4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 10::US11478451, Example 10 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 12.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572157&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591160 473133224 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207825 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C33H35ClN4O3/c1-21-29-27(35-37(21)3)20-36(2)17-6-7-18-38-31-25(15-16-26(34)30(29)31)24(32(38)33(39)40)13-9-19-41-28-14-8-11-22-10-4-5-12-23(22)28/h4-5,8,10-12,14-16H,6-7,9,13,17-20H2,1-3H3,(H,39,40) JFFOLBCOYWMQHS-UHFFFAOYSA-N 572158 (rac)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 11::US11478451, Example 11 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572158&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591225 473133225 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207826 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C33H35ClN4O3/c1-21-29-27(35-37(21)3)20-36(2)17-6-7-18-38-31-25(15-16-26(34)30(29)31)24(32(38)33(39)40)13-9-19-41-28-14-8-11-22-10-4-5-12-23(22)28/h4-5,8,10-12,14-16H,6-7,9,13,17-20H2,1-3H3,(H,39,40) JFFOLBCOYWMQHS-UHFFFAOYSA-N 572159 (+)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy) propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 12 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.520 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572159&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591225 473133226 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207827 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C33H35ClN4O3/c1-21-29-27(35-37(21)3)20-36(2)17-6-7-18-38-31-25(15-16-26(34)30(29)31)24(32(38)33(39)40)13-9-19-41-28-14-8-11-22-10-4-5-12-23(22)28/h4-5,8,10-12,14-16H,6-7,9,13,17-20H2,1-3H3,(H,39,40) JFFOLBCOYWMQHS-UHFFFAOYSA-N 572159 (+)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy) propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 12 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572159&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591225 473133226 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207828 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C33H35ClN4O3/c1-21-29-27(35-37(21)3)20-36(2)17-6-7-18-38-31-25(15-16-26(34)30(29)31)24(32(38)33(39)40)13-9-19-41-28-14-8-11-22-10-4-5-12-23(22)28/h4-5,8,10-12,14-16H,6-7,9,13,17-20H2,1-3H3,(H,39,40) JFFOLBCOYWMQHS-UHFFFAOYSA-N 572159 (+)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy) propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 12 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572159&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591225 473133226 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207829 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(35-34-20)19-36(2)16-5-6-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,34,35)(H,38,39) GELGKXVOWYYPCM-UHFFFAOYSA-N 572160 (−)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy) propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 13::US11478451, Example 13 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 26.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572160&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591720 473133227 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207830 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(33)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NDWMVESOANHLBE-UHFFFAOYSA-N 572161 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 14::US11447504, Example 16::US11478451, Example 16 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.00 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572161&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591177 473133228 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207831 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H29ClFN3O4/c1-18-27-25(35-34-18)17-39-14-3-2-13-36-29-23(11-12-24(32)28(27)29)22(30(36)31(37)38)7-5-15-40-26-8-4-6-19-16-20(33)9-10-21(19)26/h4,6,8-12,16H,2-3,5,7,13-15,17H2,1H3,(H,34,35)(H,37,38) FZKJBLJEXASDNO-UHFFFAOYSA-N 572162 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 15::US11478451, Example 17 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.490 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572162&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591079 473133229 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207832 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H29ClFN3O4/c1-18-27-25(35-34-18)17-39-14-3-2-13-36-29-23(11-12-24(32)28(27)29)22(30(36)31(37)38)7-5-15-40-26-8-4-6-19-16-20(33)9-10-21(19)26/h4,6,8-12,16H,2-3,5,7,13-15,17H2,1H3,(H,34,35)(H,37,38) FZKJBLJEXASDNO-UHFFFAOYSA-N 572162 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 15::US11478451, Example 17 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572162&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591079 473133229 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207833 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H29ClFN3O4/c1-18-27-25(35-34-18)17-39-14-3-2-13-36-29-23(11-12-24(32)28(27)29)22(30(36)31(37)38)7-5-15-40-26-8-4-6-19-16-20(33)9-10-21(19)26/h4,6,8-12,16H,2-3,5,7,13-15,17H2,1H3,(H,34,35)(H,37,38) FZKJBLJEXASDNO-UHFFFAOYSA-N 572162 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 15::US11478451, Example 17 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572162&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591079 473133229 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207834 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(33)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NDWMVESOANHLBE-UHFFFAOYSA-N 572161 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 14::US11447504, Example 16::US11478451, Example 16 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.660 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572161&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591177 473133228 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207835 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(33)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NDWMVESOANHLBE-UHFFFAOYSA-N 572161 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 14::US11447504, Example 16::US11478451, Example 16 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572161&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591177 473133228 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207836 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(33)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NDWMVESOANHLBE-UHFFFAOYSA-N 572161 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 14::US11447504, Example 16::US11478451, Example 16 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572161&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591177 473133228 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207837 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H29ClFN3O4/c1-18-27-25(35-34-18)17-39-14-3-2-13-36-29-23(11-12-24(32)28(27)29)22(30(36)31(37)38)7-5-15-40-26-8-4-6-19-16-20(33)9-10-21(19)26/h4,6,8-12,16H,2-3,5,7,13-15,17H2,1H3,(H,34,35)(H,37,38) FZKJBLJEXASDNO-UHFFFAOYSA-N 572164 (−)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 17 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 5.20 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572164&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591079 473133230 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207838 CCc1c-2c(COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-8,10-12,14-16H,3,9,13,17-20H2,1-2H3,(H,38,39)/b7-6- PYMQPCYJYGZZFS-SREVYHEPSA-N 572165 (rac)-(11 Z)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,13,15-tetrahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 18 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572165&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591275 473133231 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207839 CCc1c-2c(COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-8,10-12,14-16H,3,9,13,17-20H2,1-2H3,(H,38,39)/b7-6- PYMQPCYJYGZZFS-SREVYHEPSA-N 572165 (rac)-(11 Z)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,13,15-tetrahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 18 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572165&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591275 473133231 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207840 CCc1c-2c(COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-8,10-12,14-16H,3,9,13,17-20H2,1-2H3,(H,38,39)/b7-6- PYMQPCYJYGZZFS-SREVYHEPSA-N 572165 (rac)-(11 Z)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,13,15-tetrahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 18 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572165&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591275 473133231 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207841 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.850 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207842 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.590 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207843 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207844 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207845 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 8.90 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207846 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207847 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.450 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207848 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207849 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207850 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 15.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207851 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207852 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H30ClN3O4/c1-19-27-25(34-33-19)18-38-16-5-4-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-2-3-10-21(20)26/h2-3,6,8-10,12-14H,4-5,7,11,15-18H2,1H3,(H,33,34)(H,36,37) STPZDEATQDDZCR-UHFFFAOYSA-N 572173 4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo-[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 26::US11447504, Example 27::US11478451, Example 27 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.690 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572173&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591331 473133234 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207853 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H30ClN3O4/c1-19-27-25(34-33-19)18-38-16-5-4-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-2-3-10-21(20)26/h2-3,6,8-10,12-14H,4-5,7,11,15-18H2,1H3,(H,33,34)(H,36,37) STPZDEATQDDZCR-UHFFFAOYSA-N 572173 4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo-[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 26::US11447504, Example 27::US11478451, Example 27 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572173&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591331 473133234 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207854 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H30ClN3O4/c1-19-27-25(34-33-19)18-38-16-5-4-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-2-3-10-21(20)26/h2-3,6,8-10,12-14H,4-5,7,11,15-18H2,1H3,(H,33,34)(H,36,37) STPZDEATQDDZCR-UHFFFAOYSA-N 572173 4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo-[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 26::US11447504, Example 27::US11478451, Example 27 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572173&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591331 473133234 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207855 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H30ClN3O4/c1-19-27-25(34-33-19)18-38-16-5-4-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-2-3-10-21(20)26/h2-3,6,8-10,12-14H,4-5,7,11,15-18H2,1H3,(H,33,34)(H,36,37) STPZDEATQDDZCR-UHFFFAOYSA-N 572173 4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo-[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 26::US11447504, Example 27::US11478451, Example 27 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 18.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572173&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591331 473133234 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207856 Cc1c-2c(CNCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H31ClN4O3/c1-19-27-25(34-35(19)2)18-33-15-7-16-36-29-23(13-14-24(32)28(27)29)22(30(36)31(37)38)11-6-17-39-26-12-5-9-20-8-3-4-10-21(20)26/h3-5,8-10,12-14,33H,6-7,11,15-18H2,1-2H3,(H,37,38) UQDUQFWHFLOCHG-UHFFFAOYSA-N 572175 (rac)-12-chloro-10,11-dimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid-Formic Acid Salt::US11447504, Example 28::US11478451, Example 28 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572175&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 155123531 473133235 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207857 Cc1c-2c(CNCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H31ClN4O3/c1-19-27-25(34-35(19)2)18-33-15-7-16-36-29-23(13-14-24(32)28(27)29)22(30(36)31(37)38)11-6-17-39-26-12-5-9-20-8-3-4-10-21(20)26/h3-5,8-10,12-14,33H,6-7,11,15-18H2,1-2H3,(H,37,38) UQDUQFWHFLOCHG-UHFFFAOYSA-N 572175 (rac)-12-chloro-10,11-dimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid-Formic Acid Salt::US11447504, Example 28::US11478451, Example 28 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572175&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 155123531 473133235 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207858 Cc1c-2c(CNCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H31ClN4O3/c1-19-27-25(34-35(19)2)18-33-15-7-16-36-29-23(13-14-24(32)28(27)29)22(30(36)31(37)38)11-6-17-39-26-12-5-9-20-8-3-4-10-21(20)26/h3-5,8-10,12-14,33H,6-7,11,15-18H2,1-2H3,(H,37,38) UQDUQFWHFLOCHG-UHFFFAOYSA-N 572175 (rac)-12-chloro-10,11-dimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid-Formic Acid Salt::US11447504, Example 28::US11478451, Example 28 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572175&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 155123531 473133235 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207859 CN1CCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(34-36(20)3)19-35(2)16-8-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-18-40-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) AZNRUVYELMSHOT-UHFFFAOYSA-N 572176 (rac)-12-chloro-7,10,11-trimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid::US11447504, Example 29::US11478451, Example 29 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572176&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591196 473133236 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207860 CN1CCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(34-36(20)3)19-35(2)16-8-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-18-40-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) AZNRUVYELMSHOT-UHFFFAOYSA-N 572176 (rac)-12-chloro-7,10,11-trimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid::US11447504, Example 29::US11478451, Example 29 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572176&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591196 473133236 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207861 CN1CCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(34-36(20)3)19-35(2)16-8-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-18-40-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) AZNRUVYELMSHOT-UHFFFAOYSA-N 572176 (rac)-12-chloro-7,10,11-trimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid::US11447504, Example 29::US11478451, Example 29 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572176&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591196 473133236 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207862 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C33H34ClFN4O3/c1-20-29-27(36-38(20)3)19-37(2)15-4-5-16-39-31-25(13-14-26(34)30(29)31)24(32(39)33(40)41)9-7-17-42-28-10-6-8-21-18-22(35)11-12-23(21)28/h6,8,10-14,18H,4-5,7,9,15-17,19H2,1-3H3,(H,40,41) OGHDOPFGJXKBFT-UHFFFAOYSA-N 572177 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 30::US11478451, Example 30 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.920 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572177&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591246 473133237 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207863 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H32ClFN4O3/c1-19-28-26(36-35-19)18-37(2)14-3-4-15-38-30-24(12-13-25(33)29(28)30)23(31(38)32(39)40)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,35,36)(H,39,40) MCNVWPUURUOIIZ-UHFFFAOYSA-N 572178 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 31::US11478451, Example 32 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.710 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572178&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591090 473133238 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207864 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H32ClFN4O3/c1-19-28-26(36-35-19)18-37(2)14-3-4-15-38-30-24(12-13-25(33)29(28)30)23(31(38)32(39)40)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,35,36)(H,39,40) MCNVWPUURUOIIZ-UHFFFAOYSA-N 572178 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 31::US11478451, Example 32 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572178&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591090 473133238 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207865 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H32ClFN4O3/c1-19-28-26(36-35-19)18-37(2)14-3-4-15-38-30-24(12-13-25(33)29(28)30)23(31(38)32(39)40)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,35,36)(H,39,40) MCNVWPUURUOIIZ-UHFFFAOYSA-N 572178 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 31::US11478451, Example 32 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572178&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591090 473133238 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207866 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H32ClFN4O3/c1-19-28-26(36-35-19)18-37(2)14-3-4-15-38-30-24(12-13-25(33)29(28)30)23(31(38)32(39)40)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,35,36)(H,39,40) MCNVWPUURUOIIZ-UHFFFAOYSA-N 572179 (−)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 32 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 26.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572179&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591090 473133239 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207867 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572180 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 33::US11478451, Example 35 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.70 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572180&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133240 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207868 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572181 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11447504, Example 34 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.590 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572181&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133241 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207869 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572181 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11447504, Example 34 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572181&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133241 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207870 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572181 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11447504, Example 34 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572181&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133241 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207871 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572182 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11447504, Example 35 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 22.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572182&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133242 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207872 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.940 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207873 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572184 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 37 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.780 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572184&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133244 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207874 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572184 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 37 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572184&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133244 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207875 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572184 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 37 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572184&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133244 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207876 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572185 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 38 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 16.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572185&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133245 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207877 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.790 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207878 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207879 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207880 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207881 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 12.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207882 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 4.00 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207883 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.40 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207884 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207885 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207886 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 41.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207887 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207888 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.710 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207889 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207890 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207891 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 44.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207892 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572195 (rac)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 48::US11478451, Example 50 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.70 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572195&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133249 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207893 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572196 (+)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11447504, Example 49 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.750 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572196&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133250 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207894 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572196 (+)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11447504, Example 49 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572196&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133250 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207895 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572196 (+)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 1)::US11447504, Example 49 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572196&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133250 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207896 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572197 (−)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid (Enantiomer 2)::US11447504, Example 50 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 15.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572197&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133251 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207897 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572198 (rac)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 51::US11478451, Example 52 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.30 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572198&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133252 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207898 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572198 (rac)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 51::US11478451, Example 52 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572198&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133252 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207899 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572198 (rac)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 51::US11478451, Example 52 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572198&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133252 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207900 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572199 (+)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt—Enantiomer 1::US11447504, Example 52 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.870 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572199&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133253 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207901 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572200 (−) 4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt—Enantiomer 2::US11447504, Example 53 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 21.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572200&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133254 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207902 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207903 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207904 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207905 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.30 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207906 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 18800 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207907 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207908 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-18-32(34,35)14-15-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-16-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) BGHOHGRGKVVKET-UHFFFAOYSA-N 572203 4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt—Enantiomer 1::US11447504, Example 56::US11447504, Example 57::US11478451, Example 57 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.820 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572203&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591179 473133257 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207909 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-18-32(34,35)14-15-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-16-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) BGHOHGRGKVVKET-UHFFFAOYSA-N 572203 4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt—Enantiomer 1::US11447504, Example 56::US11447504, Example 57::US11478451, Example 57 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 23.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572203&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591179 473133257 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207910 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207911 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207912 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207913 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207914 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 50.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207915 CCc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClF4N4O3/c1-3-28-31-27(41-42(28)2)19-43(20-35(38,39)40)15-4-5-16-44-32-25(13-14-26(36)30(31)32)24(33(44)34(45)46)9-7-17-47-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18H,3-5,7,9,15-17,19-20H2,1-2H3,(H,45,46) SOQSAVNRWHIOGH-UHFFFAOYSA-N 572208 (rac) 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 61::US11447504, Example 62::US11478451, Example 61 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.40 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572208&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591302 473133259 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207916 CCc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClF4N4O3/c1-3-28-31-27(41-42(28)2)19-43(20-35(38,39)40)15-4-5-16-44-32-25(13-14-26(36)30(31)32)24(33(44)34(45)46)9-7-17-47-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18H,3-5,7,9,15-17,19-20H2,1-2H3,(H,45,46) SOQSAVNRWHIOGH-UHFFFAOYSA-N 572208 (rac) 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 61::US11447504, Example 62::US11478451, Example 61 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.70 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572208&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591302 473133259 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207917 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207918 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 4.90 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207919 Cc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-19-29-27(35-36(19)2)18-40-17-22-15-21(22)16-37-31-25(12-13-26(34)30(29)31)24(32(37)33(38)39)10-6-14-41-28-11-5-8-20-7-3-4-9-23(20)28/h3-5,7-9,11-13,21-22H,6,10,14-18H2,1-2H3,(H,38,39) NAMHEZLSLWIGJK-UHFFFAOYSA-N 572212 (9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9a, 10,10a, 11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino-[8,7,6-hi]indole-13-carboxylic Acid—Stereoisomer 1::US11447504, Example 65::US11447504, Example 66::US11478451, Example 083 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.920 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572212&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591299 473133261 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207920 Cc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-19-29-27(35-36(19)2)18-40-17-22-15-21(22)16-37-31-25(12-13-26(34)30(29)31)24(32(37)33(38)39)10-6-14-41-28-11-5-8-20-7-3-4-9-23(20)28/h3-5,7-9,11-13,21-22H,6,10,14-18H2,1-2H3,(H,38,39) NAMHEZLSLWIGJK-UHFFFAOYSA-N 572212 (9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9a, 10,10a, 11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino-[8,7,6-hi]indole-13-carboxylic Acid—Stereoisomer 1::US11447504, Example 65::US11447504, Example 66::US11478451, Example 083 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.70 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572212&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591299 473133261 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207921 Cc1nn(C)c2N(Cc3ccccc3)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc(-c12)c34 InChI=1S/C38H38N4O3/c1-26-34-32-19-11-18-30-31(20-12-24-45-33-21-10-16-28-15-6-7-17-29(28)33)36(38(43)44)42(35(30)32)23-9-8-22-41(37(34)40(2)39-26)25-27-13-4-3-5-14-27/h3-7,10-11,13-19,21H,8-9,12,20,22-25H2,1-2H3,(H,43,44) GKGARWQHJPRBIZ-UHFFFAOYSA-N 572214 (rac)-8-benzyl-9,11-dimethyl-1-[3-(1-naphthyloxy)propyl]-4,5,6,7,8,9-hexahydropyrazolo[4′,3′:4,5][1,6]diazecino[3,2,1-hi]indole-2-carboxylic Acid (Example 002) and (rac)-9,11-dimethyl-1-[3-(1-naphthyloxy)propyl]-4,5,6,7,8,9-hexahydropyrazolo[4′,3′:4,5][1,6]diazecino[3,2,1-hi]indole-2-carboxylic Acid (Example 003)::US11447504, Example 69 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 350 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572214&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 132143525 473133262 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207922 Cc1nn(C)c2NCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4cccc(-c12)c34 InChI=1S/C31H32N4O3/c1-20-27-25-14-8-13-23-24(15-9-19-38-26-16-7-11-21-10-3-4-12-22(21)26)29(31(36)37)35(28(23)25)18-6-5-17-32-30(27)34(2)33-20/h3-4,7-8,10-14,16,32H,5-6,9,15,17-19H2,1-2H3,(H,36,37) OAEVSBBSVICKIC-UHFFFAOYSA-N 572215 US11447504, Example 70 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 43.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572215&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 137251886 473133263 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207923 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35ClN4O3/c1-21-28-29-26(34)17-16-25-24(14-10-20-41-27-15-9-12-22-11-5-6-13-23(22)27)31(33(39)40)38(30(25)29)19-8-4-7-18-36(2)32(28)35-37(21)3/h5-6,9,11-13,15-17H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) CGMPYXJHHLNZIS-UHFFFAOYSA-N 572216 (rac)-4-chloro-2,3,15-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 71::US11447504, Example 72::US11447504, Example 73 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.20 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572216&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591725 473133264 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207924 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35ClN4O3/c1-21-28-29-26(34)17-16-25-24(14-10-20-41-27-15-9-12-22-11-5-6-13-23(22)27)31(33(39)40)38(30(25)29)19-8-4-7-18-36(2)32(28)35-37(21)3/h5-6,9,11-13,15-17H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) CGMPYXJHHLNZIS-UHFFFAOYSA-N 572216 (rac)-4-chloro-2,3,15-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 71::US11447504, Example 72::US11447504, Example 73 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572216&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591725 473133264 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207925 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35ClN4O3/c1-21-28-29-26(34)17-16-25-24(14-10-20-41-27-15-9-12-22-11-5-6-13-23(22)27)31(33(39)40)38(30(25)29)19-8-4-7-18-36(2)32(28)35-37(21)3/h5-6,9,11-13,15-17H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) CGMPYXJHHLNZIS-UHFFFAOYSA-N 572216 (rac)-4-chloro-2,3,15-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 71::US11447504, Example 72::US11447504, Example 73 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572216&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591725 473133264 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207926 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35ClN4O3/c1-21-28-29-26(34)17-16-25-24(14-10-20-41-27-15-9-12-22-11-5-6-13-23(22)27)31(33(39)40)38(30(25)29)19-8-4-7-18-36(2)32(28)35-37(21)3/h5-6,9,11-13,15-17H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) CGMPYXJHHLNZIS-UHFFFAOYSA-N 572216 (rac)-4-chloro-2,3,15-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 71::US11447504, Example 72::US11447504, Example 73 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.960 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572216&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591725 473133264 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207927 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35ClN4O3/c1-21-28-29-26(34)17-16-25-24(14-10-20-41-27-15-9-12-22-11-5-6-13-23(22)27)31(33(39)40)38(30(25)29)19-8-4-7-18-36(2)32(28)35-37(21)3/h5-6,9,11-13,15-17H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) CGMPYXJHHLNZIS-UHFFFAOYSA-N 572216 (rac)-4-chloro-2,3,15-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 71::US11447504, Example 72::US11447504, Example 73 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 16.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572216&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591725 473133264 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207928 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35ClN4O3/c1-21-28-29-26(34)17-16-25-24(14-10-20-41-27-15-9-12-22-11-5-6-13-23(22)27)31(33(39)40)38(30(25)29)19-8-4-7-18-36(2)32(28)35-37(21)3/h5-6,9,11-13,15-17H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) CGMPYXJHHLNZIS-UHFFFAOYSA-N 572216 (rac)-4-chloro-2,3,15-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 71::US11447504, Example 72::US11447504, Example 73 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572216&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591725 473133264 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207929 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H35ClN4O3/c1-21-28-29-26(34)17-16-25-24(14-10-20-41-27-15-9-12-22-11-5-6-13-23(22)27)31(33(39)40)38(30(25)29)19-8-4-7-18-36(2)32(28)35-37(21)3/h5-6,9,11-13,15-17H,4,7-8,10,14,18-20H2,1-3H3,(H,39,40) CGMPYXJHHLNZIS-UHFFFAOYSA-N 572216 (rac)-4-chloro-2,3,15-trimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 71::US11447504, Example 72::US11447504, Example 73 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572216&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591725 473133264 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207930 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H34ClFN4O3/c1-20-28-29-26(34)15-14-25-24(10-8-18-42-27-11-7-9-21-19-22(35)12-13-23(21)27)31(33(40)41)39(30(25)29)17-6-4-5-16-37(2)32(28)36-38(20)3/h7,9,11-15,19H,4-6,8,10,16-18H2,1-3H3,(H,40,41) OLJSHGSMKXGVPK-UHFFFAOYSA-N 572219 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,15-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 74::US11447504, Example 75::US11447504, Example 76 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572219&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591736 473133265 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207931 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H34ClFN4O3/c1-20-28-29-26(34)15-14-25-24(10-8-18-42-27-11-7-9-21-19-22(35)12-13-23(21)27)31(33(40)41)39(30(25)29)17-6-4-5-16-37(2)32(28)36-38(20)3/h7,9,11-15,19H,4-6,8,10,16-18H2,1-3H3,(H,40,41) OLJSHGSMKXGVPK-UHFFFAOYSA-N 572219 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,15-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 74::US11447504, Example 75::US11447504, Example 76 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 19000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572219&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591736 473133265 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207932 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H34ClFN4O3/c1-20-28-29-26(34)15-14-25-24(10-8-18-42-27-11-7-9-21-19-22(35)12-13-23(21)27)31(33(40)41)39(30(25)29)17-6-4-5-16-37(2)32(28)36-38(20)3/h7,9,11-15,19H,4-6,8,10,16-18H2,1-3H3,(H,40,41) OLJSHGSMKXGVPK-UHFFFAOYSA-N 572219 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,15-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 74::US11447504, Example 75::US11447504, Example 76 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572219&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591736 473133265 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207933 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H34ClFN4O3/c1-20-28-29-26(34)15-14-25-24(10-8-18-42-27-11-7-9-21-19-22(35)12-13-23(21)27)31(33(40)41)39(30(25)29)17-6-4-5-16-37(2)32(28)36-38(20)3/h7,9,11-15,19H,4-6,8,10,16-18H2,1-3H3,(H,40,41) OLJSHGSMKXGVPK-UHFFFAOYSA-N 572219 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,15-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 74::US11447504, Example 75::US11447504, Example 76 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 0.700 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572219&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591736 473133265 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207934 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H34ClFN4O3/c1-20-28-29-26(34)15-14-25-24(10-8-18-42-27-11-7-9-21-19-22(35)12-13-23(21)27)31(33(40)41)39(30(25)29)17-6-4-5-16-37(2)32(28)36-38(20)3/h7,9,11-15,19H,4-6,8,10,16-18H2,1-3H3,(H,40,41) OLJSHGSMKXGVPK-UHFFFAOYSA-N 572219 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,15-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 74::US11447504, Example 75::US11447504, Example 76 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 19000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572219&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591736 473133265 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207935 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H34ClFN4O3/c1-20-28-29-26(34)15-14-25-24(10-8-18-42-27-11-7-9-21-19-22(35)12-13-23(21)27)31(33(40)41)39(30(25)29)17-6-4-5-16-37(2)32(28)36-38(20)3/h7,9,11-15,19H,4-6,8,10,16-18H2,1-3H3,(H,40,41) OLJSHGSMKXGVPK-UHFFFAOYSA-N 572219 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,15-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 74::US11447504, Example 75::US11447504, Example 76 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572219&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591736 473133265 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207936 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H34ClFN4O3/c1-20-28-29-26(34)15-14-25-24(10-8-18-42-27-11-7-9-21-19-22(35)12-13-23(21)27)31(33(40)41)39(30(25)29)17-6-4-5-16-37(2)32(28)36-38(20)3/h7,9,11-15,19H,4-6,8,10,16-18H2,1-3H3,(H,40,41) OLJSHGSMKXGVPK-UHFFFAOYSA-N 572219 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,15-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 74::US11447504, Example 75::US11447504, Example 76 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 7.90 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572219&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591736 473133265 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207937 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H34ClFN4O3/c1-20-28-29-26(34)15-14-25-24(10-8-18-42-27-11-7-9-21-19-22(35)12-13-23(21)27)31(33(40)41)39(30(25)29)17-6-4-5-16-37(2)32(28)36-38(20)3/h7,9,11-15,19H,4-6,8,10,16-18H2,1-3H3,(H,40,41) OLJSHGSMKXGVPK-UHFFFAOYSA-N 572219 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,15-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 74::US11447504, Example 75::US11447504, Example 76 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572219&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591736 473133265 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207938 CN1CCCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc14)c23 InChI=1S/C33H34ClFN4O3/c1-20-28-29-26(34)15-14-25-24(10-8-18-42-27-11-7-9-21-19-22(35)12-13-23(21)27)31(33(40)41)39(30(25)29)17-6-4-5-16-37(2)32(28)36-38(20)3/h7,9,11-15,19H,4-6,8,10,16-18H2,1-3H3,(H,40,41) OLJSHGSMKXGVPK-UHFFFAOYSA-N 572219 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,15-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 74::US11447504, Example 75::US11447504, Example 76 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572219&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591736 473133265 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207939 CCc1c-2c(nn1C)N(C)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClFN4O3/c1-4-27-30-29-26(35)16-15-25-24(11-9-19-43-28-12-8-10-21-20-22(36)13-14-23(21)28)32(34(41)42)40(31(25)29)18-7-5-6-17-38(2)33(30)37-39(27)3/h8,10,12-16,20H,4-7,9,11,17-19H2,1-3H3,(H,41,42) ADXFNSVYTPLASR-UHFFFAOYSA-N 572222 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,15-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 77::US11447504, Example 78::US11447504, Example 79 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572222&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591768 473133266 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207940 CCc1c-2c(nn1C)N(C)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClFN4O3/c1-4-27-30-29-26(35)16-15-25-24(11-9-19-43-28-12-8-10-21-20-22(36)13-14-23(21)28)32(34(41)42)40(31(25)29)18-7-5-6-17-38(2)33(30)37-39(27)3/h8,10,12-16,20H,4-7,9,11,17-19H2,1-3H3,(H,41,42) ADXFNSVYTPLASR-UHFFFAOYSA-N 572222 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,15-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 77::US11447504, Example 78::US11447504, Example 79 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human 17000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572222&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591768 473133266 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207941 CCc1c-2c(nn1C)N(C)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClFN4O3/c1-4-27-30-29-26(35)16-15-25-24(11-9-19-43-28-12-8-10-21-20-22(36)13-14-23(21)28)32(34(41)42)40(31(25)29)18-7-5-6-17-38(2)33(30)37-39(27)3/h8,10,12-16,20H,4-7,9,11,17-19H2,1-3H3,(H,41,42) ADXFNSVYTPLASR-UHFFFAOYSA-N 572222 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,15-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 77::US11447504, Example 78::US11447504, Example 79 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572222&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591768 473133266 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207942 CCc1c-2c(nn1C)N(C)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClFN4O3/c1-4-27-30-29-26(35)16-15-25-24(11-9-19-43-28-12-8-10-21-20-22(36)13-14-23(21)28)32(34(41)42)40(31(25)29)18-7-5-6-17-38(2)33(30)37-39(27)3/h8,10,12-16,20H,4-7,9,11,17-19H2,1-3H3,(H,41,42) ADXFNSVYTPLASR-UHFFFAOYSA-N 572222 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,15-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 77::US11447504, Example 78::US11447504, Example 79 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.10 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572222&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591768 473133266 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207943 CCc1c-2c(nn1C)N(C)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClFN4O3/c1-4-27-30-29-26(35)16-15-25-24(11-9-19-43-28-12-8-10-21-20-22(36)13-14-23(21)28)32(34(41)42)40(31(25)29)18-7-5-6-17-38(2)33(30)37-39(27)3/h8,10,12-16,20H,4-7,9,11,17-19H2,1-3H3,(H,41,42) ADXFNSVYTPLASR-UHFFFAOYSA-N 572222 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,15-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 77::US11447504, Example 78::US11447504, Example 79 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572222&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591768 473133266 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207944 CCc1c-2c(nn1C)N(C)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClFN4O3/c1-4-27-30-29-26(35)16-15-25-24(11-9-19-43-28-12-8-10-21-20-22(36)13-14-23(21)28)32(34(41)42)40(31(25)29)18-7-5-6-17-38(2)33(30)37-39(27)3/h8,10,12-16,20H,4-7,9,11,17-19H2,1-3H3,(H,41,42) ADXFNSVYTPLASR-UHFFFAOYSA-N 572222 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,15-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 77::US11447504, Example 78::US11447504, Example 79 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572222&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591768 473133266 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207945 CCc1c-2c(nn1C)N(C)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClFN4O3/c1-4-27-30-29-26(35)16-15-25-24(11-9-19-43-28-12-8-10-21-20-22(36)13-14-23(21)28)32(34(41)42)40(31(25)29)18-7-5-6-17-38(2)33(30)37-39(27)3/h8,10,12-16,20H,4-7,9,11,17-19H2,1-3H3,(H,41,42) ADXFNSVYTPLASR-UHFFFAOYSA-N 572222 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,15-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 77::US11447504, Example 78::US11447504, Example 79 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 6.40 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572222&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591768 473133266 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207946 CCc1c-2c(nn1C)N(C)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClFN4O3/c1-4-27-30-29-26(35)16-15-25-24(11-9-19-43-28-12-8-10-21-20-22(36)13-14-23(21)28)32(34(41)42)40(31(25)29)18-7-5-6-17-38(2)33(30)37-39(27)3/h8,10,12-16,20H,4-7,9,11,17-19H2,1-3H3,(H,41,42) ADXFNSVYTPLASR-UHFFFAOYSA-N 572222 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,15-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 77::US11447504, Example 78::US11447504, Example 79 Apoptosis regulator Bcl-2 [1-211]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806829 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=259&target=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572222&enzyme=Apoptosis+regulator+Bcl-2+%5B1-211%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591768 473133266 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFD 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207947 CCc1c-2c(nn1C)N(C)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C34H36ClFN4O3/c1-4-27-30-29-26(35)16-15-25-24(11-9-19-43-28-12-8-10-21-20-22(36)13-14-23(21)28)32(34(41)42)40(31(25)29)18-7-5-6-17-38(2)33(30)37-39(27)3/h8,10,12-16,20H,4-7,9,11,17-19H2,1-3H3,(H,41,42) ADXFNSVYTPLASR-UHFFFAOYSA-N 572222 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,15-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 77::US11447504, Example 78::US11447504, Example 79 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2057K58 aid1806830 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572222&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591768 473133266 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1207948 CCc1c-2c(nn1C)N(CCC1CCOCC1)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O4/c1-3-33-36-35-32(41)15-14-31-30(10-8-22-50-34-11-7-9-27-25-28(42)12-13-29(27)34)38(40(47)48)46(37(31)35)20-6-4-5-19-45(39(36)43-44(33)2)21-16-26-17-23-49-24-18-26/h7,9,11-15,25-26H,3-6,8,10,16-24H2,1-2H3,(H,47,48) HHGPCAJGMHOKIL-UHFFFAOYSA-N 572225 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(oxan-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 80::US11447504, Example 81::US11447504, Example 82 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.00 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572225&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591741 473133267 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207949 CCc1c-2c(nn1C)N(CCC1CCOCC1)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O4/c1-3-33-36-35-32(41)15-14-31-30(10-8-22-50-34-11-7-9-27-25-28(42)12-13-29(27)34)38(40(47)48)46(37(31)35)20-6-4-5-19-45(39(36)43-44(33)2)21-16-26-17-23-49-24-18-26/h7,9,11-15,25-26H,3-6,8,10,16-24H2,1-2H3,(H,47,48) HHGPCAJGMHOKIL-UHFFFAOYSA-N 572225 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(oxan-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 80::US11447504, Example 81::US11447504, Example 82 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572225&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591741 473133267 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207950 CCc1c-2c(nn1C)N(CCC1CCOCC1)CCCCCn1c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c-2c13 InChI=1S/C40H46ClFN4O4/c1-3-33-36-35-32(41)15-14-31-30(10-8-22-50-34-11-7-9-27-25-28(42)12-13-29(27)34)38(40(47)48)46(37(31)35)20-6-4-5-19-45(39(36)43-44(33)2)21-16-26-17-23-49-24-18-26/h7,9,11-15,25-26H,3-6,8,10,16-24H2,1-2H3,(H,47,48) HHGPCAJGMHOKIL-UHFFFAOYSA-N 572225 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(oxan-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5][1,6]diazacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 80::US11447504, Example 81::US11447504, Example 82 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 140 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572225&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591741 473133267 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207951 Cc1c-2c(OCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-27-28-25(33)14-13-24-23(9-7-17-40-26-10-6-8-20-18-21(34)11-12-22(20)26)30(32(38)39)37(29(24)28)15-4-3-5-16-41-31(27)35-36(19)2/h6,8,10-14,18H,3-5,7,9,15-17H2,1-2H3,(H,38,39) OMYQPDVOHAOLPZ-UHFFFAOYSA-N 572228 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-11,12,13,14-tetrahydro-2H,10H-pyrazolo[3′,4′:2,3][1,6]oxazacycloundecino[4,5,6-hi]indole-8-carboxylic Acid::US11447504, Example 83::US11447504, Example 84::US11447504, Example 85 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 4.50 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572228&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591717 473133268 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207952 Cc1c-2c(OCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-27-28-25(33)14-13-24-23(9-7-17-40-26-10-6-8-20-18-21(34)11-12-22(20)26)30(32(38)39)37(29(24)28)15-4-3-5-16-41-31(27)35-36(19)2/h6,8,10-14,18H,3-5,7,9,15-17H2,1-2H3,(H,38,39) OMYQPDVOHAOLPZ-UHFFFAOYSA-N 572228 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-11,12,13,14-tetrahydro-2H,10H-pyrazolo[3′,4′:2,3][1,6]oxazacycloundecino[4,5,6-hi]indole-8-carboxylic Acid::US11447504, Example 83::US11447504, Example 84::US11447504, Example 85 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.90 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572228&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591717 473133268 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1207953 Cc1c-2c(OCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-27-28-25(33)14-13-24-23(9-7-17-40-26-10-6-8-20-18-21(34)11-12-22(20)26)30(32(38)39)37(29(24)28)15-4-3-5-16-41-31(27)35-36(19)2/h6,8,10-14,18H,3-5,7,9,15-17H2,1-2H3,(H,38,39) OMYQPDVOHAOLPZ-UHFFFAOYSA-N 572228 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-11,12,13,14-tetrahydro-2H,10H-pyrazolo[3′,4′:2,3][1,6]oxazacycloundecino[4,5,6-hi]indole-8-carboxylic Acid::US11447504, Example 83::US11447504, Example 84::US11447504, Example 85 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 53.0 US Patent 10.7270/Q2057K58 aid1806828 US11447504 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Mortier, JX; McCarren, PR; Serrano-Wu, MH; Lemke, C; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 9/20/2022 11/20/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572228&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591717 473133268 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589